OraSure Technologies.
medical device company
- Reports this week
- 0
- Active events
- 0
- Connections
- 28
What's happening
One to three months ago
Gone quiet
No new reports in 90+ days-
MarketBeat has reported consensus ratings for OraSure Technologies, which is listed on the Nasdaq stock exchange.Some support1 report
-
OraSure Technologies appointed Ken McGrath as its new Chief Financial Officer.Some support1 report
-
Sherlock Biosciences and DNA Genotek Inc. are now wholly-owned subsidiaries of OTI.Some support2 reports
-
OraSure Technologies established a new relationship with Targeted Genomics and renewed an agreement with gene Dx on August 6, 2025.Some support1 report
-
David Nierenberg made portfolio updates on August 12, 2025, including increased stakes in Lyft, OraSure Technologies, Criteo SA, and Green Dot Corp.Some support1 report
-
OraSure Technologies operates within the U.S. stock market, and there is M&A interest from Ron Zwanziger.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around OraSure Technologies this week
News at the entities that move OraSure Technologies most-
FDA StructuralFDA issued a warning letter to NeoGen regarding a product quality defect on October 7, 2026.Moves OraSure Technologies
-
MarketBeat Mentioned togetherMarketBeat used its stock screener tool to highlight Walmart.Moves OraSure Technologies
-
Uganda OperationalThe Ministry of Public Service is operating within Uganda.Moves OraSure Technologies
-
Hoffmann-La Roche StructuralOmar Khwaja, a Fellow of the Royal College of Physicians, leads clinical research at Cancer Research UK.Moves OraSure Technologies
-
Democratic Republic of the Congo Shared contextUganda and the Democratic Republic of the Congo share mountain gorilla populations, and large freshwater bodies support agricultural needs in the region.Moves OraSure Technologies
-
Nasdaq StructuralGolub Capital BDC, Inc. listed on the electronic stock exchange.Moves OraSure Technologies
Connections
The 8 strongest of 28, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Ken McGrath Structural
OraSure appointed Ken McGrath to the role of Chief Financial Officer (CFO).
-
FDA Structural
FDA granted Emergency Use Authorization to OraSure Technologies.
-
Scott Gleason Structural
Scott Gleason served as interim CFO for OraSure Technologies during its scaling phase.
-
Nasdaq Structural
OraSure Technologies is listed on the Nasdaq stock exchange.
-
Hoffmann-La Roche Structural
OraSure supplies testing kits that are utilized by Hoffmann-La Roche for its procedures.
-
Uganda Operational
OraSure Technologies' testing capabilities are being utilized to support containment efforts during an outbreak in Uganda.
-
MarketBeat Mentioned together
MarketBeat provides consensus ratings and financial analysis for OraSure Technologies.
-
Democratic Republic of the Congo Shared context
OraSure Technologies operates within the context of containment efforts during an outbreak in the Democratic Republic of the Congo.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
2 eventsJune 2026
4 events- Sherlock Biosciences and DNA Genotek Inc. are now wholly-owned subsidiaries of OTI.
- OraSure Technologies established a new relationship with Targeted Genomics and renewed an agreement with gene Dx on August 6, 2025.
- David Nierenberg made portfolio updates on August 12, 2025, including increased stakes in Lyft, OraSure Technologies, Criteo SA, and Green Dot Corp.
- OraSure Technologies operates within the U.S. stock market, and there is M&A interest from Ron Zwanziger.